Celldex Therapeutics Inc is a biotechnology company that develops antibodies and immunomodulators to enhance the body's immune response. The company's pipeline consists of therapeutic antibodies, antibody drug conjugates, immune system modulators, and vaccines. The company is engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer.